131 related articles for article (PubMed ID: 8330289)
1. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models.
Ghosh M; Bhattacharya S; Sadhu U; Dutta S; Sanyal U
Cancer Lett; 1997 Oct; 119(1):7-12. PubMed ID: 18372515
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
4. Antitumour activity of Annona muricata L. leaf methanol extracts against Ehrlich Ascites Carcinoma and Dalton's Lymphoma Ascites mediated tumours in Swiss albino mice.
Naik AV; Dessai SN; Sellappan K
Libyan J Med; 2021 Dec; 16(1):1846862. PubMed ID: 33380281
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
9. Antitumour principles from Nigella sativa seeds.
Salomi NJ; Nair SC; Jayawardhanan KK; Varghese CD; Panikkar KR
Cancer Lett; 1992 Mar; 63(1):41-6. PubMed ID: 1555206
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
11. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
Jugstand W; Gutsche W; Wiangke H
Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
[No Abstract] [Full Text] [Related]
12. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluoren-NU as a novel antitumor agent.
Mukherjee A; Dutta S; Chashoo G; Bhagat M; Saxena AK; Sanyal U
Oncol Res; 2009; 17(9):387-96. PubMed ID: 19718945
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and antitumour principles from Ixora coccinea flowers.
Latha PG; Panikkar KR
Cancer Lett; 1998 Aug; 130(1-2):197-202. PubMed ID: 9751274
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G
J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405
[TBL] [Abstract][Full Text] [Related]
18. [The synthesis and carcinostatic effect of 4-[bis-(2-chloroethyl)-amino]-2, 3-dimethyl-1-phenyl-5-pyrazolone ("imet 3995")].
Werner W; Jungstand W; Gutsche W; Wohlrabe K
Pharmazie; 1975 Jul; 30(7):433-5. PubMed ID: 1178756
[No Abstract] [Full Text] [Related]
19. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
Sanyal U; Dutta S; Das H
Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.
Pazdur R; Redman BG; Corbett T; Phillips M; Baker LH
Cancer Res; 1987 Aug; 47(15):4213-7. PubMed ID: 3607760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
